Genitourinary Oncology Program, H. Lee Moffitt Cancer Center, Tampa, Florida 33612-9416, USA.
Urology. 2011 Jan;77(1):217-22. doi: 10.1016/j.urology.2010.02.047. Epub 2010 May 15.
Patients with genitourinary tumors and inferior vena cava thrombus often have large lesions and significant neovascularity. Early division of the renal vein with the in situ thrombus is desirable; however, concerns have been raised regarding tumor spillage and thrombus migration. We describe a novel technique using a stapling device to secure the renal vein during resection of renal tumors associated with an inferior vena cava thrombus.
Since 2005, 38 patients have undergone surgery for genitourinary tumors and inferior vena cava tumor thrombus by a single surgeon. We examined the utility of an endovascular stapler (Endo-GIA) to transect the renal vein and the in situ thrombus. The renal vein containing the tumor thrombus was divided with an endovascular stapler in 14 of 38 patients. The outcomes of this technique were assessed.
The stapled group included more level III-IV thrombi than the nonstapled group. The tumors removed in the stapled group were larger (median 11.5 versus 9 cm), and the median intraoperative transfusion requirements were greater (9.5 versus 3 U). One patient developed an intraoperative pulmonary embolus, and another experienced hemodynamic changes suggestive of an embolus. Local recurrence developed in 1 and 2 patients in the stapled and conventional groups, respectively, during a median follow-up period of 3 months.
The Endo-GIA stapler is a safe and effective instrument for division of the in situ renal vein component of the tumor thrombus, allowing the surgeon to complete the nephrectomy, achieve hemostasis, and, subsequently, concentrate on the vena cava and tumor thrombus aspects of the procedure.
患有泌尿生殖系统肿瘤和下腔静脉血栓的患者通常存在较大的病变和明显的新生血管。理想情况下,应尽早原位分离肾静脉和血栓;然而,人们对肿瘤漏出和血栓迁移的问题表示担忧。我们介绍了一种新的技术,使用吻合器在切除与下腔静脉血栓相关的肾肿瘤时固定肾静脉。
自 2005 年以来,由一名外科医生对 38 例泌尿生殖系统肿瘤和下腔静脉肿瘤血栓患者进行了手术。我们研究了使用血管内吻合器(Endo-GIA)横断肾静脉和原位血栓的效果。在 38 例患者中有 14 例采用血管内吻合器横断包含肿瘤血栓的肾静脉。评估了该技术的效果。
吻合组比非吻合组的 III-IV 级血栓更多。吻合组切除的肿瘤更大(中位数为 11.5 厘米 vs 9 厘米),术中输血需求中位数更大(9.5 单位 vs 3 单位)。1 例患者术中发生肺栓塞,另 1 例患者出现提示栓塞的血流动力学变化。在中位随访 3 个月期间,吻合组和常规组分别有 1 例和 2 例患者局部复发。
Endo-GIA 吻合器是一种安全有效的工具,可用于横断肿瘤血栓的原位肾静脉部分,使外科医生能够完成肾切除术、实现止血,然后集中精力处理腔静脉和肿瘤血栓方面的问题。